Cited by 296Retinoids in leukemia and cellular processesPeroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism

Direct Channeling of Retinoic Acid between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest

Open access
Budhu, Anuradha S., Noy, Noa·2002·Molecular and Cellular Biology

Abstract

Cellular retinoic acid-binding protein II (CRABP-II) is an intracellular lipid-binding protein that associates with retinoic acid with a subnanomolar affinity. We previously showed that CRABP-II enhances the transcriptional activity of the nuclear receptor with which it shares a common ligand, namely, the retinoic acid receptor (RAR), and we suggested that it may act by delivering retinoic acid to this receptor. Here, the mechanisms underlying the effects of CRABP-II on the transcriptional activity of RAR and the functional consequences of these effects were studied. We show that CRABP-II, a predominantly cytosolic protein, massively undergoes nuclear localization upon binding of retinoic acid; that it interacts with RAR in a ligand-dependent fashion; and that, in the presence of retinoic acid, the CRABP-II-RAR complex is a short-lived intermediate. The data establish that potentiation of the transcriptional activity of RAR stems directly from the ability of CRABP-II to channel retinoic acid to the receptor. We demonstrate further that overexpression of CRABP-II in MCF-7 mammary carcinoma cells dramatically enhances their sensitivity to retinoic acid-induced growth inhibition. Conversely, diminished expression of CRABP-II renders these cells retinoic acid resistant. Taken together, the data unequivocally establish the function of CRABP-II in modulating the RAR-mediated biological activities of retinoic acid.

Integrity signals

Registry

Crossref · 10.1128/mcb.22.8.2632-2641.2002

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the cytosol, RA binds CRABPII, which belongs to the intracellular lipid binding protein (iLBP) family.

    “In the cytosol, RA is well known to bind the cellular retinoic acid-binding protein CRABPII, which belongs to the intracellular lipid binding proteins iLBP family.”
  • The resulting complex channels RA from the binding protein to the RAR and markedly facilitates the formation of the liganded receptor.

    “The resulting complex channels RA from the binding protein to the RAR and markedly facilitates the formation of the liganded receptor.”
  • CRABPII specifically associates with RA with subnanomolar affinities.

    “It is a small cytosolic protein, which specifi cally associates with RA with subnanomolar affi nities.”
  • CRABPII significantly enhances the transcriptional activity of RARs and sensitizes the cells to RA biological activities.

    “It was demonstrated that by directly delivering RA to RARs, CRABPII significantly enhances the transcriptional activity of RARs and sensitizes the cells to RA biological activities.”
  • Upon binding of RA, CRABPII mobilizes to the nucleus, where it associates with RARs through direct protein-protein interactions.

    “Upon binding of RA, CRABPII mobilizes to the nucleus, where it associates with RARs through direct protein-protein interactions (17)(18)(19).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Budhu, A. S., & Noy, N.
Affiliations
Cornell University (US)
Venue
Molecular and Cellular Biology
Published
2002-04-01
Volume
22
Issue
8
Pages
2632-2641
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2122256734
Cited by
296
References
4
Citations by year
2026: 4 · 2025: 2 · 2024: 7 · 2023: 5 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 7 · 2018: 12 · 2017: 9 · 2016: 16 · 2015: 14 · 2014: 19 · 2013: 11 · 2012: 20
FWCI
4.76
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (CA 68150, R01CA068150)
  • National Institute of Diabetes and Digestive and Kidney Diseases (5-T32-DK07158, T32DK007158)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
CRABP2, retinoic acid receptor, retinoic acid, nuclear localization, transcriptional activity, breast cancer, MCF-7 cells, growth arrest, retinoic acid resistance, nuclear receptor ligand binding
MeSH terms
Animals, Biological Transport, Active, Breast Neoplasms, Cell Division, Female, Humans, Ligands, Models, Biological, Recombinant Fusion Proteins, Transcription, Genetic, Tretinoin, Receptors, Retinoic Acid, COS Cells, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review